The International Association for the Study of Lung Cancer (IASLC) shared a post on X:
“Host Narjust Florez, MD moderates a discussion on management of early-stage disease with an eye toward applying conclusions from trials such as the ADAURA and the recent ESMO/ELCC data about perioperative chemo-immunotherapy. With Dr. Leticia Lauricella and Delvys Rodriguez Abreu.”
Read further.
Source: IASLC/X